Imides
US5605914A · kind A · utility
66Cited by
1References
32Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jun 10, 1994 |
| Grant date | Feb 25, 1997 |
| Priority date | — |
| Expiry date | Jun 10, 2014 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D405/12
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Cyclic imides are inhibitors of tumor necrosis factor .alpha. and can be used to combat cachexia, endotoxic shock, and retrovirus replication. A typical embodiment is 2-(2,6-dioxo-3-piperidinyl)-4-azaisoindoline-1,3-dione.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.